Pancreas-Plus, No. 112, 90 Capsules, Dietary Supplement

NatureAll-Stf Holding, LLC recalled Pancreas-Plus, No. 112, 90 Capsules, Dietary Supplement in a Class II action, the FDA tier for products that may cause temporary or medically reversible health effects on Jul 26, 2017.

The FDA listed the reason as an undeclared allergen: "Undeclared allergens: soy (lecithin)" Allergen mislabeling is the leading cause of U.S. food recalls, because a missing declaration can trigger a reaction in someone who reads the label and believes the product is safe.

Distribution was broad: the FDA record describes it as "Nationwide, US: CA, FL, GA, ID, IL, IN, TX, UT, WA, WY. No foreign or govt/VA/military consignees," which places this among the wider-reach recalls on the site. Consumers across the affected area should check product on hand. The recalling firm is based in Salt Lake City, UT. The recall covers 566 bottles of product. The FDA has Terminated this recall (first reported Aug 23, 2017), its final lifecycle state, indicating the agency considers the corrective action resolved. The historical record remains useful for tracking a brand's recall pattern over time.